Lyophilization of vaccines.
However effective a therapeutic agent may appear during clinical trials, its full potential as a marketable product can only be assured if the material can be stored and distributed in a stabilized form. This is particularly the case with labile biologlcals, such as attenuated vaccines, especially when these products need to be transported in tropical regions with limited distribution infrastructure.